Search Results 3311-3320 of 25319 for oral
The overall objective of this study is to examine if the strategy starting of the addition of a tsDMARD, oral targeted molecule medications will lead to ...
Subject has taken any oral, injectable, or IV glucocorticoids within 8 weeks from time of screening visit, or plans to take any oral, injectable, or IV ...
* Oral corticosteroid (OCS; prednisone or equivalent) background therapy is permitted but not required. For participants taking OCS, the dose must be stable ...
o Dissemination through an oral presentation to a panel of peers and instructors and submission of a manuscript deemed suitable for publication in a peer ...
Oral;; Intravaginal;; Transdermal. Progestogen-only hormonal contraception associated with inhibition of ovulation: Oral;; Injectable;; Implantable. Double ...
... oral absorption or tolerance of treatment; Treatment with any investigational products within 60 days before the first dose of the study drug regimen ...
Multicenter, open-label phase II study of daily oral regorafenib for chemotherapy-refractory, metastatic and locally advanced angiosarcoma. Ann Oncol. 2018 ...
Oral carbohydrate loading has been shown to attenuate the development of insulin resistance in the non-pregnant population undergoing many different types of ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift now to help create new and better solutions for the more than 1.3 million patients who turn to Mayo Clinic each year.